基本信息
views: 0
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Mirko Diksic made a significant contribution to oncological brain research. Soon after the installation of the cyclotron, one of the first radioactively labeled radiopharmaceuticals was a drug named Carmustine (1,3 di-chloroethylen nitrosourea, BCNU), that is often used in the treatment of brain tumors. Mirko Diksic was first to demonstrate that the effects of BCNU depend on its routes of administration. Using PET studies, it was determined that 11C-BCNU following intra-arterial administration accumulated in brain tumors 50% more than after intravenous administration.
Research Interests
Papers共 349 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Elesa Zehndorfer, GA Akerlof, GS Aldrete, A Aldrete, A Anderson,AM Andersson,E Carlsen,JH Petersen,NE Skakkebaek, G Andruszliewicz, M Davis, S Lleo,
The Physiology of Emotional and Irrational Investing: Causes and Solutionsno. 1 (2018): 1-36
Cited302Views0Bibtex
302
0
Mirko Diksic, Victor Swoboda
Neurochemistry internationalno. 8 (2012): 1417-23
Load More
Author Statistics
#Papers: 192
#Citation: 6480
H-Index: 39
G-Index: 74
Sociability: 6
Diversity: 1
Activity: 0
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn